Treatment of vancomycin-resistant Enterococcus faecium infections

Archives of Internal Medicine

Volumn 156, Issue 22, 1996, Pages 2579-2584

  Lai, Kwan Kew ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DALFOPRISTIN; DALFOPRISTIN PLUS QUINUPRISTIN; QUINUPRISTIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL PERITONITIS; CLINICAL ARTICLE; DEBRIDEMENT; FEMALE; HUMAN; MALE; PELVIS ABSCESS; POSTOPERATIVE INFECTION; PRIORITY JOURNAL;

ABDOMINAL ABSCESS; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; ENTEROCOCCUS FAECIUM; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; PERITONITIS; SOFT TISSUE INFECTIONS; SURGICAL WOUND INFECTION; TREATMENT OUTCOME; URINARY TRACT INFECTIONS; VANCOMYCIN; VIRGINIAMYCIN;

EID: 10544233012     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.156.22.2579     Document Type: Article

References (27)

1. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med. 1988;319: 157-161.
2. Uttley AH, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci. Lancet. 1988;1:57-58.
3. Nosocomial enterococci resistant to vancomycin - United States, 1989-1993. MMWR Morb Mortal Wkly Rep. 1993;42:597-599.
4. Murray BE. Enterococci: how to make a second-rate pathogen into a first-rate problem. In: Programs and abstracts of the 34th annual meeting of the Infectious Diseases Society of America; September 18-20, 1996; New Orleans, La.
5. Spera RV Jr, Farber BF. Multiply-resistance Enterococcus faecium: the nosocomial pathogen of the 1990s. JAMA. 1992;268:2563-2564.
6. Standiford HD, DeMaine JB, Kirby WM. Antibiotic synergism of enterococci: relation to inhibitory concentrations. Arch Intern Med. 1970;126:255-259.
7. Moellering RC Jr, Wennersten C, Weinberg AN. Synergy of penicillin and gentamicin against Enterococci. J Infect Dis. 1971;124(suppl):207S-209S.
8. 14C-labelled streptomycin by enterococci. J Clin Invest. 1971;50:2580-2584.
9. Mederski-Samoraj BD, Murray BE. High-level resistance to gentamicin in clinical isolates of enterococci. J Infect Dis. 1983;147:751-757.
10. Zervos MJ, Dembinski S, Mikesell T, Schaberg DR. High-level resistance to gentamicin in Streptococcus faecalis: risk factors and evidence for exogenous acquisition of infection. J Infect Dis. 1986;153:1075-1083.
11. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16:128-140.
12. National Committee for Clinical Laboratory Procedures. Methods for Dilution: Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. 3rd ed. Villanova, Pa: National Committee for Clinical Laboratory Standards; 1993.
13. National Committee for Clinical Laboratory Procedures. Performance Standards for Antimicrobial Disk Susceptibility Tests. 5th ed. Villanova, Pa: National Committee for Clinical Laboratory Standards; 1993.
14. Woods GL, Washington JA. Antibacterial susceptibility tests: dilution and disk diffusion methods. In: Murray PA, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiology. 6th ed. Washington, DC: American Society for Microbiology; 1995:1327-1341.
15. Johnson AP, Uttley AHC, Woodford N, George RC. Resistance to vancomycin and teicoplanin: an emerging clinical problem. Clin Microbiol Rev. 1990;3:280-291.
16. Kaplan AH, Gilligan PH, Facklam RR. Recovery of resistant enterococci during vancomycin prophylaxis. J Clin Microbiol. 1988;26:1216-1218.
17. Leclercq R, Bingen E, Su OH, Lambert-Zechovsky N, Courvalin P, Duval J. Effects of combinations of beta-lactams, daptomycin, gentamicin and glycopeptides against glycopeptide-resistant enterococci. Antimicrob Agents Chemother. 1991;35:92-98.
18. Shlaes DM, Etter L, Guttmann L. Synergistic killing of vancomycin-resistant enterococci of classes A, B, and C by combinations of vancomycin, penicillin and gentamicin. Antimicrob Agents Chemother. 1991;35:776-779.
19. Ikeda DP, Barry AL, Anderson SG. Emergence of Streptococcus faecalis isolates with high-level resistance to multiple aminocyclitol aminoglycosides. Diagn Microbiol Infect Dis. 1984;2:171-177.
20. Bingen E, Lambert-Zechovsky N, Leclercq R, Doit C, Mariani-Kurdjian P. Bactericidal activity of vancomycin, daptomycin, ampicillin and aminoglycosides against vancomycin resistant Enterococci faecium. J Antimicrob Chemother. 1990;26:619-626.
21. Barriere JC, Bouanchaud DH, Paris JM, Rolin O, Harris NV, Smith C. Antimicrobial activity against Staphylococcus aureus of semisynthetic injectable streptogramins: RP59500 and related compounds. J Antimicrob Chemother. 1992; 30(suppl A):1-8.
22. Fass RJ. In vitro activity of RP59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococci. Antimicrob Agents Chemother. 1991;35:553-559.
23. Goto S, Miyazaki S, Ono A, Kaneko Y. The in vitro antibacterial activity of RP59500 against gram-positive cocci. In: Programs and abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy; October 21-24,1990; Atlanta, Ga. Abstract.
24. Maple PAC, Hamilton-Miler JMT, Brumfitt W. World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus. Lancet. 1989;1:537-539.
25. Collins LA, Malanoski GJ, Eliopoulos GM, Wennersten CB, Ferraro MJ, Moelering RC Jr. In vitro activity of RP 59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms. Antimicrob Agents Chemother. 1993;37:598-601.
26. Norris AH, Reilly JP, Edelstein PH, Brennan PJ, Schuster MG. Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections. Clin Infect Dis. 1995;20:1137-1144.
27. Hardalo C, Rigsby M, Chen L. Chloramphenicol treatment of resistant Enterococcus faecium. In: Program and abstracts of the 31st Meeting of the Infectious Diseases Society of America; October 15-17, 1993; New Orleans, La.